Our COVID-19 news
We are committed to communicating with the public about our COVID-19 research. Our experts engage with the media to provide thought leadership and information you can trust.
Browse our news and press mentions below in full. We've also chosen to list a few highlights.
- Public engagement: A panel of Monash BDI scientists discuss how the world moves forward with COVID-19 –from vaccine development and public health policy, to the future of healthcare, and the importance of how research in shaping tomorrow. COVID-19 Where to next: watch the recording here. 26 May 2020.
- Expert commentary: Until we know more about the coronavirus, loosening COVID-19 restrictions and resuming our normal lives could be a mistake. 6 May 2020
- Research: A philanthropic donation will fully fund the important next steps in research on the use of the FDA approved, anti-parasitic drug Ivermectin to combat COVID-19. This donation will enable the study (published in Antiviral Research) to move from the in-vitro phase to pre-clinical trials. Read about the initial study: Lab experiments show anti-parasitic drug, Ivermectin, eliminates SARS-CoV-2 in cells in 48 hours.21 May 2020
- Community awareness: Professor Stephen Turner responds directly to questions from toddlers and children, explaining the virus and why social distancing is important, on SBS Insight 2 April 2020